Showing results (81-90 of 120) with videos related to

Sort By:
Pageof 12
Acta Ophthalmologica|December 5, 2025
Seasonal variation in the incidence of central serous chorioretinopathy: A systematic review and meta-analysisI Made Ferdiko Hutamadella, Emil Ørnberg, Mark P Breazzano, et al.
American Journal of Ophthalmology|July 2, 2021
Half-Dose Photodynamic Therapy Versus Eplerenone in Chronic Central Serous Chorioretinopathy (SPECTRA): A Randomized Controlled TrialThomas J van Rijssen, Elon H C van Dijk, Roula Tsonaka, et al.
The British Journal of Ophthalmology|July 14, 2018
Discrepancy in current central serous chorioretinopathy classificationSumit Randhir Singh, Alexandre Matet, Elon H C van Dijk, et al.
Retina (Philadelphia, Pa.)|December 1, 2017
FAMILIAL CENTRAL SEROUS CHORIORETINOPATHYElon H C van Dijk, Rosa L Schellevis, Myrte B Breukink, et al.
Sleep|February 27, 2026
Sex and age modulate the relationship between melanopsin-dependent light sensitivity and chronotypeGijs van der Zwet, Zoë Bor, Roos Bos, et al.
Journal of Clinical Medicine|October 26, 2024
Symptomatic Vitreous Opacities: Exploring the Mismatch between Clinical Observation of Vitreous Alterations and Self-Reported SymptomsGiulio Bamonte, Clemente Maria Iodice, Rodolfo Mastropasqua, et al.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|May 25, 2019
Patient characteristics of untreated chronic central serous chorioretinopathy patients with focal versus diffuse leakageThomas J van Rijssen, Elon H C van Dijk, Paula Scholz, et al.
American Journal of Ophthalmology|April 15, 2020
Crossover to Photodynamic Therapy or Micropulse Laser After Failure of Primary Treatment of Chronic Central Serous Chorioretinopathy: The REPLACE TrialThomas J van Rijssen, Elon H C van Dijk, Paula Scholz, et al.
American Journal of Ophthalmology|March 18, 2026
Long-term follow-up of PLACE and SPECTRA trials: outcomes after successful and unsuccessful half-dose photodynamic therapy for chronic central serous chorioretinopathyFemke M van den Tillaart, Jennifer M Chang-Wolf, Helena M A Feenstra, et al.
Trials|September 23, 2015
Comparing half-dose photodynamic therapy with high-density subthreshold micropulse laser treatment in patients with chronic central serous chorioretinopathy (the PLACE trial): study protocol for a randomized controlled trialMyrte B Breukink, Susan M Downes, Giuseppe Querques, et al.
Pageof 12